{"id":7040295,"date":"2026-08-17T04:51:09","date_gmt":"2026-08-17T04:51:09","guid":{"rendered":"https:\/\/peraltafinancing.com\/uncategorized\/optellum-and-coreline-soft-plan-ai-integration-for-lung-nodule-care\/"},"modified":"2026-08-17T04:51:09","modified_gmt":"2026-08-17T04:51:09","slug":"optellum-and-coreline-soft-plan-ai-integration-for-lung-nodule-care","status":"publish","type":"post","link":"https:\/\/fivemor.com\/?p=7040295","title":{"rendered":"Optellum and Coreline Soft plan AI integration for lung nodule care"},"content":{"rendered":"


\n<\/p>\n

\n
\n
\n \"\"\/\n <\/picture>
The LungOS platform is designed for screening incidental lung nodules. Credit: create jobs 51\/Shutterstock.com.<\/figcaption><\/figure>\n<\/p><\/div>\n

Optellum and Coreline Soft have announced plans to integrate AI to support lung nodule detection and management across international markets and multiple disease areas.<\/p>\n

Under the partnership, Coreline Soft\u2019s Food and Drug Administration (FDA)-cleared computer-aided detection (CADe) software, AVIEW Lung Nodule CAD, will be made available on Optellum\u2019s AI-powered LungOS platform.<\/p>\n

\n
\n
\"\"\/<\/figure>\n

Discover B2B Marketing That Performs <\/h4>\n

\n\t\t\t\t\t\tCombine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.\n\t\t\t\t\t<\/p>\n


\n\t\t\t\t\t\t\tFind out more <\/svg><\/span><\/a><\/p>\n<\/section>\n<\/div>\n

The proposal seeks to combine Coreline Soft\u2019s image-based CADe capabilities with Optellum\u2019s CADx, risk assessment, and care management solutions.<\/p>\n

This would provide clinicians with a streamlined approach for detection, prioritisation, and follow-up of lung nodule patients.<\/p>\n

Optellum CEO Dr Johnathan Watkins said: \u201cOptellum is building LungOS into a unified operating system for lung cancer and thoracic care more broadly. Our intended collaboration with Coreline Soft reflects a shared commitment to giving clinicians and health systems the tools they need to support earlier, more confident lung nodule assessment.<\/p>\n

\u201cCoreline Soft\u2019s commitment to clinical rigor and combined excellence has underpinned its strong track record in AI-enabled nodule detection. This is highly complementary to Optellum\u2019s leadership in reimbursed nodule risk assessment and management. Together, we aim to support a future where no lung nodule patient is left behind.\u201d<\/p>\n

Coreline Soft CEO Jin Kook Kim said: \u201cCoreline Soft has been committed to advancing AI technologies that support radiologists, pulmonologists, and multidisciplinary care teams in lung cancer care.<\/p>\n

\u201cWe are pleased to explore this potential collaboration with Optellum. Optellum\u2019s LungOS platform and Virtual Nodule Clinic help healthcare institutions manage the care pathway for patients with lung nodules in a more structured way.\u201d<\/p>\n

The platform is designed for opportunistic screening of incidental lung nodules and features the Optellum Virtual Nodule Clinic with Patient Discovery AI and Lung Cancer Prediction AI.<\/p>\n

The Optellum Virtual Nodule Clinic is cleared for use with incidental lung nodules in the US and Australia, and for screening-detected and incidental lung nodules in Switzerland, the UK and the EU.<\/p>\n

<\/p>\n

<\/p>\n

\n